Harbour Investments Inc. lowered its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 32.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,173 shares of the company's stock after selling 6,241 shares during the period. Harbour Investments Inc.'s holdings in American Healthcare REIT were worth $399,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Wolff Wiese Magana LLC purchased a new stake in shares of American Healthcare REIT during the 1st quarter worth $25,000. MassMutual Private Wealth & Trust FSB lifted its position in shares of American Healthcare REIT by 189.0% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock valued at $29,000 after buying an additional 633 shares during the last quarter. Spirit of America Management Corp NY bought a new stake in shares of American Healthcare REIT in the 1st quarter valued at about $30,000. Continuum Advisory LLC purchased a new position in shares of American Healthcare REIT in the 1st quarter worth approximately $37,000. Finally, Tsfg LLC bought a new position in shares of American Healthcare REIT during the 1st quarter worth approximately $41,000. Institutional investors own 16.68% of the company's stock.
Insider Activity at American Healthcare REIT
In other news, CIO Stefan K.L. Oh sold 3,860 shares of the stock in a transaction on Monday, June 30th. The shares were sold at an average price of $36.10, for a total value of $139,346.00. Following the sale, the executive owned 95,671 shares in the company, valued at $3,453,723.10. This represents a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.92% of the stock is owned by company insiders.
American Healthcare REIT Stock Performance
AHR traded down $0.43 on Wednesday, reaching $39.63. 1,515,967 shares of the stock were exchanged, compared to its average volume of 1,077,971. The company has a debt-to-equity ratio of 0.45, a current ratio of 0.38 and a quick ratio of 0.38. The company's 50-day moving average price is $36.66 and its 200 day moving average price is $32.50. The firm has a market capitalization of $6.32 billion, a PE ratio of -146.76, a PEG ratio of 2.25 and a beta of 1.08. American Healthcare REIT, Inc. has a fifty-two week low of $16.29 and a fifty-two week high of $40.56.
American Healthcare REIT (NYSE:AHR - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. The firm had revenue of $540.60 million during the quarter, compared to analysts' expectations of $542.32 million. American Healthcare REIT had a negative return on equity of 1.85% and a negative net margin of 1.96%. The company's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period last year, the business posted $0.30 earnings per share. As a group, sell-side analysts forecast that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.
American Healthcare REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 18th. Stockholders of record on Monday, June 30th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, June 30th. American Healthcare REIT's dividend payout ratio is -370.37%.
Analysts Set New Price Targets
Several brokerages have weighed in on AHR. Robert W. Baird started coverage on shares of American Healthcare REIT in a research note on Friday, July 18th. They issued an "outperform" rating and a $41.00 target price for the company. Truist Financial raised their price objective on American Healthcare REIT from $32.00 to $38.00 and gave the stock a "buy" rating in a research report on Monday, June 9th. Jefferies Financial Group began coverage on American Healthcare REIT in a research report on Monday, April 28th. They set a "buy" rating and a $37.00 target price on the stock. Baird R W upgraded American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. Finally, Scotiabank started coverage on American Healthcare REIT in a research note on Monday, June 30th. They set a "sector outperform" rating and a $42.00 price target on the stock. Ten equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Buy" and an average target price of $38.11.
Read Our Latest Report on American Healthcare REIT
About American Healthcare REIT
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Read More

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.